
June 25, 2025
Wakely White Paper Projects Major ACA Marketplace Disruption Under House Reconciliation Bill
HMA Insights – including our new podcast – puts the vast depth of HMA’s expertise at your fingertips, helping you stay informed about the latest healthcare trends and topics. Below, you can easily search based on your topic of interest to find useful information from our podcast, blogs, webinars, case studies, reports and more.

Wakely White Paper Projects Major ACA Marketplace Disruption Under House Reconciliation Bill

This webinar was held on July 10, 2025.
Watch for an in-depth discussion on the future of the individual market and the impacts of potential Congressional and regulatory changes to the Affordable Care Act (ACA). This webinar explored findings from a new Wakely report which estimates that ACA enrollment could decrease by 11 to 13 million as a result of these pending changes, representing a 47% to 57% decline. The report also projects that market average premiums could increase between 7% and 11.5% on top of claims trend. The report’s analysis considers a range of influential factors, including provisions in the House budget reconciliation bill, the Marketplace Integrity and Affordability regulation, and the scheduled expiration of enhanced premium tax credits in 2026. HMA, Wakely, and Leavitt Partners experts unpacked the current federal and state policy landscape and their potential effects on coverage access, affordability, and the long-term viability of the individual market.
Learning Objectives:
Download the webinar transcript here.
Download the webinar Q&A here.

A new white paper released today by Wakely Consulting Group, an HMA Company, (Wakely) examines the potential enrollment and premium impacts of the House budget reconciliation bill, H.R. 1, and the expiring subsidies for the ACA Individual Market.

This webinar was held on July 9, 2025.
This webinar explored the current state of maternal health in the U.S., with a focus on persistent disparities, recent policy and funding shifts, and the practical realities facing programs on the ground. Kimberly Seals highlighted how external support, and strategic partnerships can help organizations navigate constraints, sharpen their approach, and strengthen impact in a rapidly changing environment.
Learning Objectives:
Featured Speaker:
Kimberly Seals, MPH, Founder Public Health Savvy

As states and stakeholders seek greater transparency and accountability in Medicaid, a new analysis from Health Management Associates (HMA), offers a fresh perspective on how dollars flow through the system. Drawing on publicly available data from the Transformed Medicaid Statistical Information System (T-MSIS), HMA disaggregated funding dispersed to Medicaid managed care organizations to discern spending for specific categorically eligible populations. The findings significantly enhance policy discussions and can facilitate development of pragmatic and specific care management interventions that support quality patient care.
For policymakers, regulators, and other stakeholders, this level of disaggregation provides a clearer view of how public dollars are used—and where there may be opportunities to improve performance or reinvest savings. It also supports more informed rate development and contract negotiations, particularly as states pursue value-based purchasing and other reforms. As Medicaid continues to evolve, especially in the context of budget pressures and changes in enrollment and risk profiles of enrollees, understanding the financial picture of managed care programs is essential to ensuring sustainability.
HMA’s team of experts—including actuaries, former Medicaid directors, and data analysts—has deep experience working with T-MSIS data and advising states, plans, and providers on Medicaid program analysis, evaluation, and strategy. For more information about working with T-MSIS data and the insights it can provide, contact our experts below.

As the US Senate debates H.R. 1—a sweeping legislative package that the House passed on May 22, 2025, which would impose nationwide Medicaid work and community engagement requirements by the end of 2026— Health Management Associates’ (HMA’s) latest analysis offers insights into the potential impact of these changes. Drawing on Transformed Medicaid Statistical Information System (T-MSIS) data, HMA experts examine the health and demographic profiles of the approximately 16 million individuals who comprise the Medicaid expansion population.
This 10-slide presentation of findings underscores the high prevalence of chronic and behavioral health conditions among these individuals, raising important questions about how new eligibility requirements could affect access to care and health outcomes. Notably, the presentation contextualizes health needs with Medicaid spending patterns, comparing the Medicaid expansion group with other eligibility categories, such as dual eligibles and children. We explore how the proposals of the nine state 1115 demonstration applications could affect the work requirements policy and implementation landscape. It also breaks down pharmacy spending by therapeutic class, spotlighting common conditions like opioid use disorder.
These insights are especially valuable for Medicaid managed care organizations, providers, and other stakeholders that will play a key role in designing work requirement initiatives and operationalizing any new requirements. Our May 22, 2025, article—Building State Capacities for Medicaid Work and Community Engagement Requirements—delves into the issues that are central to such discussions.
With deep expertise in Medicaid policy, demonstration design, and advanced analytics, HMA is uniquely positioned to help states, plans, and providers navigate the evolving federal landscape. For more information about HMA’s T-MSIS capabilities, contact featured experts below.

On March 4, 2025, the Centers for Medicare & Medicaid Services (CMS) rescinded the 2023 and 2024 guidance on Health-Related Social Needs (HRSN) Section 1115 demonstrations. This policy shift signals a significant pivot in federal Medicaid priorities under the current administration. While states with approved HRSN demonstrations may continue operating under existing terms, the path forward for pending proposals and future renewals is less certain.
This article explores key considerations Health Management Associates (HMA), experts identified for states that need to realign HRSN activities with other activities to align with the Trump Administration’s federal policy objectives and priorities for Section 1115 Medicaid and CHIP demonstrations.
In November 2023 and December 2024, CMS published guidance on a new Section 1115 demonstration that gave state Medicaid and CHIP agencies the opportunity to address the broad environmental conditions, or social determinants of health (SDOH), that affect people’s health. This initiative permitted states to address the individual-level adverse social conditions of enrollees that contribute to negative health outcomes. To assist states in their efforts, CMS approved Section 1115 demonstrations that piloted the provision of housing, food, non-medical transportation, and other environmental supports that meet enrollees’ HRSNs.
First, CMS’s March 4 rescission has no impact on states with a current, active Section 1115 demonstration that includes HRSN. States with HRSN demonstrations can maintain their approved programs until the scheduled expiration date; however, requests to amend any aspect of the program before it expires could subject the state to renegotiation of HRSN components that align with the new federal direction.
Second, states with pending HRSN Section 1115 demonstration proposals should proactively consider new coverage approaches to authorize services that address an individual’s SDOH. Pending proposals developed using the now rescinded guidance may require substantial changes to gain approval. States should also prepare for additional public comment periods if revisions significantly alter the original design.
Looking ahead, CMS is not expected to renew demonstration components that no longer align with current federal objectives. This projection pertains to any demonstration component, not just the rescinded HRSN guidance. States should start planning now for how they will sustain successful HRSN-related outcomes through alternative coverage pathways.
While the HRSN guidance has been rescinded, CMS has not withdrawn the 2021 State Health Official Letter RE: Opportunities in Medicaid and CHIP to Address Social Determinants of Health (SDOH) (SHO# 21-001), published during the first Trump Administration. This leaves room for states to pivot HRSN initiatives into other federal authorities, such as:
As states recalibrate their Medicaid and CHIP strategies, understanding how they can align with evolving federal priorities is critical for all stakeholders. Notably, Medicaid stakeholders, including managed care organizations, hospitals and health systems, and providers, also have several opportunities, including:
HMA’s team—including former CMS Section 1115 leaders and other colleagues steeped in Medicaid and CHIP policies and operations—offers unique expertise in designing demonstrations that reflect current federal policy priorities and maximize state outcomes in alignment with program objectives that CMS will support.
For questions about these developments and your organization’s plan to adapt to new federal Medicaid policy priorities, contact our featured experts below. Connect with our experts and other leaders experienced in new pathways for covering effective services at the HMA National Conference, October 14-16, 2025, in New Orleans, LA.

This webinar was held on June 26, 2025.
Non-Emergency Medical Transportation (NEMT) is a vital Medicaid benefit designed to ensure that individuals without access to reliable transportation receive critical healthcare services, especially for those with chronic conditions. This session explored the foundational purpose of NEMT and its role in ensuring members access the care they need, improving care outcomes, and advancing health equity by addressing transportation barriers. We examined how services are currently delivered—ranging from traditional ride scheduling to managed transportation brokers—and discussed the growing role of technology and innovation in streamlining operations, enhancing member experience, and curbing fraud, waste, and abuse. Attendees also gained insight into how the NEMT landscape is evolving in response to Medicaid reforms, value-based care initiatives, and the integration of social determinants of health (SDOH).
Learning Objectives:
Featured Speakers:
Sufian Chowdhury, Founder and CEO Kinetik
Peter J. Hicks, Executive Director Non-Emergency Medical Transportation Accreditation Commission
Tammy Mihm, Director of Compliance Oversight NEMT TennCare

Health Management Associates (HMA), a leading health and human services consulting company, is pleased to announce that Matt Allen has joined the firm as Chief Growth Officer (CGO). As the firm’s first CGO, he will report to Chief Executive Officer Chuck Milligan and work out of HMA’s Washington, D.C., office.
Matt brings more than 25 years of diverse experience in the healthcare sector and a proven track record of advancing growth and innovation to HMA. He will shape the firm’s enterprise-wide growth initiatives, oversee strategic partnerships and help guide efforts that continue to advance innovation to meet current and emerging client needs.
“Matt is an excellent addition to our executive leadership team and will work closely with our business leaders to drive HMA’s growth strategy,” Milligan said. “He is a proven and dynamic leader who will help unlock opportunities to serve our clients and partners now and well into the future.”
Prior to joining HMA, Matt was Avalere Health’s practice director and senior vice president of Client Partnerships. In this role, he led global business development, strategic growth initiatives, and marketing. During his tenure, he advanced through a series of senior leadership positions and played a pivotal role in steering the organization through major transitions.
Previously, Matt advised health system and physician practices on revenue growth and patient-acquisition strategies as part of Optum’s legacy Advisory Board Company data and analytics practices. His experience also includes having led business development at public data startup Poplicus, Inc., and serving as a vice president at healthcare policy firm Marwood Group. He began his career in Johnson & Johnson’s pharmaceutical division with various roles in finance, field sales, managed care marketing, and brand analytics.

This 10-slide presentation, Medicaid Expansion: Data-Driven Insights into Healthcare Needs, offers a focused analysis of the Medicaid Expansion population—non-disabled adults ages 19–64 with incomes up to 138% of the Federal Poverty Level—across more than 40 states. Using recent T-MSIS data, the deck highlights the high prevalence of chronic and behavioral health conditions within this group, while also detailing demographic trends among the approximately 16 million enrollees.
Developed by Matt Powers, Shreyas Ramani, Loren Anthes, and Lora Saunders, the presentation contextualizes health needs with Medicaid spending patterns, comparing the Expansion group to other eligibility categories, such as dual eligibles and children. It also breaks down pharmacy spending by therapeutic class, spotlighting common conditions like opioid use disorder. In light of recent federal legislative proposals such as H.R. 1, the deck explores how states are beginning to navigate policy changes through 1115 waiver activity—particularly around medically frail and good cause exemptions—offering early insight into likely implementation strategies.

Today, we celebrate a significant milestone for HMA – 40 years of advancing healthcare, improving lives, and addressing the challenges that matter most.
Over the decades, we’ve had the privilege of partnering with many clients across the nation to tackle healthcare’s most pressing issues, applying our deep expertise every step of the way.
As we reflect on our 40-year journey and what we have built, we refocus ourselves on what it takes to become a leading healthcare and human services consulting firm. Looking down that road ahead, we are investing in the human experiences, analytical and digital tools, and methods to deepen our value—working with our clients and partners to create a healthier future for everyone in our country.